Hypothyroidism and Thyroiditis after Therapy for Hodgkin’s Disease

Publisher： Karger

E-ISSN： 1421-9662|109|1|11-17

ISSN： 0001-5792

Source： Acta Haematologica, Vol.109, Iss.1, 2002-12, pp. : 11-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk of Basal Cell Carcinoma after Hodgkin’s Disease

By  

Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. : 169-171

Karger

Access to resources Recommend Favorite

Adoptive T-Cell Therapy for Epstein-Barr Virus-Positive Hodgkin’s Disease

By  

Acta Haematologica, Vol. 110, Iss. 2-3, 2003-10 ,pp. : 149-153

Karger

Access to resources Recommend Favorite

High-Dose Therapy and Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Disease: Outcome Based on a Prognostic Model

By  

Acta Haematologica, Vol. 110, Iss. 4, 2003-12 ,pp. : 173-178

Karger

Access to resources Recommend Favorite

Systemic to Pulmonary Fistulas in Hodgkin’s Disease

By  

Respiration, Vol. 67, Iss. 4, 2000-07 ,pp. : 453-455

Karger

Access to resources Recommend Favorite

Synchronous Hodgkin’s Disease and Gastric Adenocarcinoma

By  

Oncology, Vol. 73, Iss. 5-6, 2008-06 ,pp. : 422-425

Karger

Access to resources Recommend Favorite